Screening of Anti-atherogenic Substances from Insect Resources |
Park, Doo-Sang
(Insect Resources Laboratory, Korea Research Institute of Bioscience and Biotechnology)
Yoon, Mi-Ae (Insect Resources Laboratory, Korea Research Institute of Bioscience and Biotechnology) Xu, Ming-Zhe (Insect Resources Laboratory, Korea Research Institute of Bioscience and Biotechnology) Yu, Ha-Na (Lipid Metabolism Research Laboratory, Korea Research Institute of Bioscience and Biotechnology) Kim, Ju-Ryoung (Lipid Metabolism Research Laboratory, Korea Research Institute of Bioscience and Biotechnology) Jeong, Tae-Sook (Lipid Metabolism Research Laboratory, Korea Research Institute of Bioscience and Biotechnology) Park, Ho-Yong (Insect Resources Laboratory, Korea Research Institute of Bioscience and Biotechnology) |
1 | Glass, C. K. and Witztum, J. L. (2001) Atherosclerosis: The road ahead. Cell 104: 503-516 DOI ScienceOn |
2 | Buhman, K. K., Accad, M., Novak, S., Choi, R. S., Wong, J. S., Hamilton, R. L., Turley, S., and Farese, R. V. Jr. (2000) Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice. Nautre Med. 6: 1341-1347 DOI ScienceOn |
3 | Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248254 DOI PUBMED ScienceOn |
4 | Jeong, T. S., Kim, S. U., Son, K. H., Kwon, B. M., Kim, Y. K., Choi, M. D., a,nd Bok, S. H. (1995) GERI-BPOOI compounds, new inhibitors of Acyl-CoA:cholesterol acyltransferase from Aspergillus fumigatus F37. I. Production, isolation, and physico-chemical and biological properties. J. Antibiotics 48: 751-756 DOI ScienceOn |
5 | Xu, M.-Z., Lee, W. S., Kim, M. J., Park, D.-S., Yu, H., Tian, G.-R., Jeong, T.-S., and Park, H.-Y. (2004) Acyl-CoA: cholesterol acyltransferase inhibitory activities of fatty acid arnides isolated from Mylabris phalerate Pallas Bioorg. Med. Chem. Lett., 14: 4277-4280 DOI ScienceOn |
6 | Havel, R. J., Edger, H. A, and Bradgon, J. H. (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353 DOI ScienceOn |
7 | Jessup, W. and Kritharides L. (2000) Metabolism of oxidized LDL by macrophages. Curro Opin. lipidol., 11: 473-481 DOI ScienceOn |
8 | Suckling, E. S. and Macphee, C. H. (2002) Lipoproteinassociated phospholipase : a tagget directed at the atheroslcerotic plaque. Expert Opin. Ther. Targets 6: 309-413 DOI ScienceOn |
9 | Packard, C. J., O'Reilly, S. J., Caslake, M. J., McMahon, A. D., Ford, I., Cooney, J., Macphee, C. H., Suckling, K E., Krishna, M., Wilkinson, F. E., Rumley, A. and Lowe. G. D. O. (2000) Lipoprotein associated phospholipase A2 asindependent predictor of coronarY heart disease. N. Engl. 1. Med. 343: 1148-1155 DOI ScienceOn |
10 | Accad, M., Smith S. J., Newland, D. L., Sanan, D. A, King, L. E. Jr, Linton, M. F, Fazio, S., and Farese, R. V. Jr. (2000) Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1. J. Clin. Invest. 105: 711-719 DOI ScienceOn |
11 | Erickson, S. K., Shrewsbury, M. A, Brooks, C., and Meyer, D. J. (1980) Rat liver acyl coemzyme A:cholesterol acyltransferase: its regulation in vivo and some of its properties in vitro. J. Lipid Res. 21: 930-941 |
12 | Ahn, B. T., Lee, S., Lee, S. B., Lee, E. S., Kim, J. G., Bok, S. H., and Jeong, T. S. (2001) Low-density lipoprotein-antioxidant constituents of Saururus chinensis. J. Nat. Prod. 64: 1562-1564 DOI ScienceOn |
13 | Macphee, C. H. (2001) Lipoprotein-associated phospholipase : a potential new risk factor for coronary qrtery disease and a therapeutic target. Curro Opin. Pharmacol. 1: 121: a potential new risk factor for coronary qrtery disease and a therapeutic target. Curro Opin. Pharmacol. 1: 121-125 DOI PUBMED ScienceOn |
14 | Hurt-Camejo, E., Camejo, G., Peilot, H., Oomi, K., and Kovanen, P. Phospholipase in vascular disease. (2001) Circ. Res. 89: 298-304 DOI ScienceOn |
15 | Ross, R. (1999) Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340: 233-241 |
16 | Chang, T. Y., Chang, C. C. Y., and Cheng, D. (1997) Acylcoenzyme A : cholesterol acyltransferase. Annu. Rev. Biochem. 66: 613-638 DOI ScienceOn |
17 | Bloomer, J. C., Boyd, H. F, Hickey, D. M. B., Ife, R. J., Leach, C. A, Macphee, C. H., Miller, K J., Pinto, I. L., Rawlings, D. A, Smith, S. A., et al. (2001) 1-(arylpiperazinylarnidoalkyl)-pyrimidones: orally active inhibitors of lipoprotein-assiciated phospholipase . Bioorg. Med. Chem. Lett., 11:1925-1929 DOI ScienceOn |
18 | Lusis, A. J. (2000) Atherosclerosis. Nature 407: 233-241 DOI PUBMED ScienceOn |
19 | Bays, H. and Stein, E. A. Pharmacotherapy for dyslipidemia - current therapies and future agents. (2003) Expert Opin. Pharmacother. 4: 1901-1938 DOI ScienceOn |
20 | Bjorkhem, I., Henriksson-Freyschuss, A, Breuer, O., Diczfalusy, U. Berglund, L., and Henriksson, P. (1991) The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arterioscler. Thromb. 11: 15-22 DOI PUBMED |
21 | Brecher, P. and Chan, C. (1980) Properties of Acyl-CoA : Chdlesteml acyltransflitase in aortic rrlittosomcs froth atherosclerotic rabbit. Biochim. Biophys. Acta 617: 458-471 DOI ScienceOn |
22 | Steinberg, D.; Parthasarathy, S.; Carew, T. E.; Khoo, J. C.; Witztum, J. L. (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 1989, 320, 915-924 DOI ScienceOn |
23 | Prescott, S. M., Zimmerman, G. A, Stafforini, D. M., and Mcintyre, T. M. (2000) Platelet activating factor and related lipid mediators. Ann. Rev.' Biochem. 69: 419-445 DOI ScienceOn |
24 | MacPhee, C. H., Moores, K. E., Boyd, H. F., Dhanak, D., Ife, R. J., Leach, C. A, Leake, D. S., Milliner, K. J., Patterson, R. A, Suckling, K. E., 'few, D. G., and Hickey, D. M. (1999) Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor. J. Biochem. 338: 479-487 DOI ScienceOn |
25 | Cho, K H., An, S. J., Lee, W. S., Paik, Y. K, Kim, Y. K., and Jeong. T. S. (2003) ;Mass-production of human ACAT-l and ACAT-2 to screen isoform-specific inhibitor: a different substrate specificity and inhibitory regulation. Biochem. Biophysic. Res. Comm. 309: 864-872 DOI ScienceOn |
26 | Yu, H. N., Sok, D. E., and Jeong, T. S. (2003) Inhibitory effects of natural plant extracts on lipoprotein-associated phospholipase Az inhibitor. Kor. J. Pharmacogn. 34: 100-108 |
27 | Boyd, H. F, Fell, S. C. M., Flynn, S. T., Hickey, D. M. B., life, R. J., Leach, C. A, Macphee, C. H., Milliner, K J., Moores, K. E., Pinto, I. L. (2002) N-l substituted pyrimidine-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase Bioorg. Med. Chem. Lett., 10: 2557-2561 DOI ScienceOn |
28 | Rudel, L. L. (2001) Acyl coenzyme A:cholesterol acyltransferade type 1 and 2 : structure and function in atherosclerosis. Curro opin. lipidol. 12: 121-127 DOI ScienceOn |